Clinical trial
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema Using SCORAD, Patient Questionnaires and Skin Hydration Measurements
NCT06453512 is registered in ClinicalTrials.gov with Dermal Laboratories Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema Using SCORAD, Patient Questionnaires and Skin Hydration Measurements
- Lead sponsor
- Dermal Laboratories Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 30, 2024
- Completion date
- October 1, 2025
- Enrollment
- 65 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic eczema